Hem › Interstitiella lungsjukdomar › Kalifornien › Los Angeles
Kliniska studier för Interstitiella lungsjukdomar i Los Angeles, CA
14 studier för Interstitiella lungsjukdomar söker deltagare vid platser i och runt Los Angeles (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
RekryterarFas 3
- University of Southern California, Los Angeles
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
RekryterarFas 3
- University of California Los Angeles, Los Angeles
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RekryterarFas 3
- USA010, Los Angeles
- USA023, Los Angeles
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
RekryterarFas 3
- GSK Investigational Site, Los Angeles
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
RekryterarFas 3
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
RekryterarFas 2/3
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
RekryterarFas 2
- University of Southern California, Los Angeles
- Cedars Sinai Medical Center, Los Angeles
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
RekryterarFas 3
- David Geffen School of Medicine at UCLA, Los Angeles
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RekryterarObservationsstudie
- Cedars-Sinai Medical Center, Los Angeles
Platform Clinical Study for Conquering Scleroderma
RekryterarFas 2
- Keck School of Medicine at USC Medical Center, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
RekryterarObservationsstudie
- University of California - Los Angeles, Los Angeles
- University of Southern California, Los Angeles
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
RekryterarFas 3
- Peter Morton Medical Building, Los Angeles
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
RekryterarFas 2
- Keck School of Medicine of USC, Los Angeles
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
RekryterarFas 2
- aTyr Investigative Site, Los Angeles
Interstitiella lungsjukdomar-studier i andra städer
- New York City, NY18 studier
- Philadelphia, PA16 studier
- Charleston, SC13 studier
- Kansas City, KS13 studier
- Durham, NC13 studier
- Chicago, IL12 studier
- Houston, TX12 studier
- Aurora, CO11 studier
- Ann Arbor, MI11 studier
- Salt Lake City, UT9 studier
- Dallas, TX9 studier
- Boston, MA9 studier
Andra studier i Los Angeles
- Icke-småcellig lungcancer87 studier
- Cancer (alla typer)74 studier
- Bröstcancer73 studier
- Prostatacancer61 studier
- Kolorektal cancer59 studier
- Metastaserande cancer57 studier
- Äggstockscancer50 studier
- Lungcancer45 studier
- Plattenepitelcancer i huvud och hals42 studier
- Bukspottkörtelcancer35 studier
- Endometriecancer34 studier
- Melanom34 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.